期刊文献+

Protective effects and mechanisms of Lizhong decoction(理中汤) against non-alcoholic fatty liver disease in a rat model 被引量:1

原文传递
导出
摘要 OBJECTIVE: To investigate the protective effects and molecular mechanisms of Lizhong decoction( 理中汤, LZD) against non-alcoholic fatty liver disease(NAFLD). METHODS: Male Wistar rats were fed a high-fat diet for four weeks to induce NAFLD, and were administered LZD by gavage for four weeks. Potential therapeutic targets for NAFLD were analyzed using network pharmacology. Liver pathology was evaluated using Oil Red O and hematoxylin-eosin staining. Furthermore, mitochondrial function, lipid metabolism, oxidative stress, and inflammatory response were examined. RESULTS: Rats with NAFLD exhibited high levels of hepatic damage and cholesterol deposition. Moreover, apoptosis was increased, superoxide dismutase and glutathione content were reduced, malondialdehyde content was increased, and the protein expression of inflammatory cytokines and p-c-Jun N-terminal kinase was increased. The LZD treatment ameliorated mitochondrial dysfunction, reduced liver damage,inhibited oxidative stress and inflammatory response, upregulated peroxisome proliferator-activated receptor(PPAR)-γ expression, and suppressed dipeptidyl peptidase 4(DPP4) expression in the liver. CONCLUSION: It was found that LZD alleviates NAFLD by activating PPAR-γ and inhibiting DPP4.
出处 《Journal of Traditional Chinese Medicine》 SCIE CSCD 2022年第5期773-780,共8页 中医杂志(英文版)
基金 Supported by Backbone Talents for TCM Clinical Characteristic Technology Inheritance Foundation of State Administration of Traditional Chinese Medicine:Protective Effects and Mechanisms of Lizhong Decoction Against Non-Alcoholic Fatty Liver Disease in a Rat Model [National Education Letter of Traditional Chinese Medicine (2018) No. 224]。
  • 相关文献

参考文献2

二级参考文献14

  • 1Pierluigi Marzuillo,Emanuele Miraglia del Giudice,Nicola Santoro.Pediatric non-alcoholic fatty liver disease:New insights and future directions[J].World Journal of Hepatology,2014,6(4):217-225. 被引量:4
  • 2Yan-Yan Ma,Lin Li,Chao-Hui Yu,Zhe Shen,Li-Hua Chen,You-Ming Li.Effects of probiotics on nonalcoholic fatty liver disease:A meta-analysis[J].World Journal of Gastroenterology,2013,19(40):6911-6918. 被引量:30
  • 3Adnan Said.Non-alcoholic fatty liver disease and liver transplantation:Outcomes and advances[J].World Journal of Gastroenterology,2013,19(48):9146-9155. 被引量:15
  • 4Sunder Mudaliar,Robert R. Henry,Arun J. Sanyal,Linda Morrow,Hanns-Ulrich Marschall,Mark Kipnes,Luciano Adorini,Cathi I. Sciacca,Paul Clopton,Erin Castelloe,Paul Dillon,Mark Pruzanski,David Shapiro.Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease[J].Gastroenterology.2013
  • 5Shaohua Chen,Narci C Teoh,Shiv Chitturi,Geoffrey C Farrell.Coffee and non‐alcoholic fatty liver disease: Brewing evidence for hepatoprotection?[J].J Gastroenterol Hepatol.2014(3)
  • 6Martin Rossmeisl,Dasa Medrikova,Evert M. van Schothorst,Jana Pavlisova,Ondrej Kuda,Michal Hensler,Kristina Bardova,Pavel Flachs,Barbora Stankova,Marek Vecka,Eva Tvrzicka,Ales Zak,Jaap Keijer,Jan Kopecky.Omega-3 phospholipids from fish suppress hepatic steatosis by integrated inhibition of biosynthetic pathways in dietary obese mice[J].BBA - Molecular and Cell Biology of Lipids.2014(2)
  • 7R. Kwok,Y.‐K. Tse,G. L.‐H. Wong,Y. Ha,A. U. Lee,M. C. Ngu,H. L.‐Y. Chan,V. W.‐S. Wong.Systematic review with meta‐analysis: non‐invasive assessment of non‐alcoholic fatty liver disease – the role of transient elastography and plasma cytokeratin‐18 fragments[J].Aliment Pharmacol Ther.2014(3)
  • 8Hellan K. Kwon,Joel K. Greenson,Hari S. Conjeevaram.Effect of lifetime alcohol consumption on the histological severity of non‐alcoholic fatty liver disease[J].Liver Int.2014(1)
  • 9Jean P. Molleston,Jeffrey B. Schwimmer,Katherine P. Yates,Karen F. Murray,Oscar W. Cummings,Joel E. Lavine,Elizabeth M. Brunt,Ann O. Scheimann,Aynur Unalp-Arida.Histological Abnormalities in Children with Nonalcoholic Fatty Liver Disease and Normal or Mildly Elevated Alanine Aminotransferase Levels[J].The Journal of Pediatrics.2013
  • 10J. H. Hoofnagle,M. L. Natta,D. E. Kleiner,J. M. Clark,K. V. Kowdley,R. Loomba,B. A. Neuschwander‐Tetri,A. J. Sanyal,J. Tonascia.Vitamin E and changes in serum alanine aminotransferase levels in patients with non‐alcoholic steatohepatitis[J].Aliment Pharmacol Ther.2013(2)

共引文献44

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部